Latest filing published 20 Nov 2024 for Syros Pharmaceuticals, Inc.. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Conley Chee on record concern Syros Pharmaceuticals, Inc. Between 31 March 2023 and 18 November 2024, the trades on record add up to 6 filings.
The open-market side counts 1 purchase alongside 1 sale. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 option exercises. Since January 2024: 1 purchase and 1 sale on the market.
On 20 November 2024 came the latest disclosure, an open-market sale in Syros Pharmaceuticals, Inc. The clock since the last published purchase (12 September 2024) now reads 766 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations